{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["38(42)"],"submitter":["Escaned J"],"funding":["National Institutes of Health"],"pubmed_abstract":["<h4>Aims</h4>To investigate if recent technical and procedural developments in percutaneous coronary intervention (PCI) significantly influence outcomes in appropriately selected patients with three-vessel (3VD) coronary artery disease.<h4>Methods and results</h4>The SYNTAX II study is a multicenter, all-comers, open-label, single arm study that investigated the impact of a contemporary PCI strategy on clinical outcomes in patients with 3VD in 22 centres from four European countries. The SYNTAX-II strategy includes: heart team decision-making utilizing the SYNTAX Score II (a clinical tool combining anatomical and clinical factors), coronary physiology guided revascularisation, implantation of thin strut bioresorbable-polymer drug-eluting stents, intravascular ultrasound (IVUS) guided stent"],"journal":["European heart journal"],"pagination":["3124-3134"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5837643"],"repository":["biostudies-literature"],"pubmed_title":["Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study."],"pmcid":["PMC5837643"],"pubmed_authors":["Ochala A","Hanratty C","Ryan N","Onuma Y","Ej West N","Stables RH","van Es GA","Fath-Ordoubadi F","Serruys PW","Cruz-Gonzalez I","Sabate M","Hildick-Smith D","Hoole SP","Appleby C","Uren N","Zueco J","Taggart DP","Farooq V","Piek JJ","Iniguez A","van Geuns RJ","Walsh S","Dudek D","Lesiak M","Buszman P","Kappetein AP","Morel MA","Escaned J","Zaman A","Cavalcante R","Collet C","Moreno R","De Maria GL","Davies J","van Mieghem N","Banning AP","de Vries T","Goicolea J"],"additional_accession":[]},"is_claimable":false,"name":"Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.","description":"<h4>Aims</h4>To investigate if recent technical and procedural developments in percutaneous coronary intervention (PCI) significantly influence outcomes in appropriately selected patients with three-vessel (3VD) coronary artery disease.<h4>Methods and results</h4>The SYNTAX II study is a multicenter, all-comers, open-label, single arm study that investigated the impact of a contemporary PCI strategy on clinical outcomes in patients with 3VD in 22 centres from four European countries. The SYNTAX-II strategy includes: heart team decision-making utilizing the SYNTAX Score II (a clinical tool combining anatomical and clinical factors), coronary physiology guided revascularisation, implantation of thin strut bioresorbable-polymer drug-eluting stents, intravascular ultrasound (IVUS) guided stent","dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Nov","modification":"2026-05-05T23:14:07.713Z","creation":"2019-03-26T23:06:54Z"},"accession":"S-EPMC5837643","cross_references":{"pubmed":["29020367"],"doi":["10.1093/eurheartj/ehx512"]}}